Related references
Note: Only part of the references are listed.Efficacy of tailored treatment for high- and low-risk medulloblastoma in adults: A large prospective phase II trial.
A. A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
What Role Should Cilengitide Have in the Treatment of Glioblastoma?
Marc C. Chamberlain
JOURNAL OF CLINICAL ONCOLOGY (2010)
ANG1005: Results of a phase I study in patients with recurrent malignant glioma
J. Drappatz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase II study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma (rGBM)
D. Schiff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
Roger Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Antiangiogenic therapies for high-grade glioma
Andrew D. Norden et al.
NATURE REVIEWS NEUROLOGY (2009)
Radiotherapy for glioblastoma in the elderly
Florence Keime-Guibert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial
W Roa et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas
M Glantz et al.
CANCER (2003)
Share Paper
